Alto Neuroscience(ANRO)
MOUNTAIN VIEW, CABiotechnology
Focus: Alto Neuroscience is an AI-driven biotechnology company focused on developing brain biomarkers to match patients with psychiatric and neurological therapies. The company is publicly traded and headquartered in Mountain View, CA, with a concentrated pipeline in Major Depressive Disorder.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Alto Neuroscience
AI assessmentNot HiringNo open roles listed right now. Follow Alto Neuroscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ALTO-101
SchizophreniaClinical Trials (1)
NCT06502964Study of ALTO-101 in Patients With Schizophrenia
Phase 2Help build intelligence for Alto Neuroscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.